(Q42651277)

4 November 2017

Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist (English)

1 reference

4 November 2017

1 reference

6

S Bates

1 reference

4 November 2017

3

A T Fojo

1 reference

4 November 2017

R M Lush

1

1 reference

4 November 2017

B Meadows

2

1 reference

4 November 2017

G Kalafsky

4

1 reference

4 November 2017

H T Smith

5

1 reference

4 November 2017

W D Figg

7

1 reference

4 November 2017

1 February 1997

1 reference

The Journal of Clinical Pharmacology

4 November 2017

1 reference

4 November 2017

37

1 reference

4 November 2017

2

1 reference

4 November 2017

123-128

1 reference

Reduced permeability in CHO cells as a mechanism of resistance to colchicine

4 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Isolation and genetic characterization of human KB cell lines resistant to multiple drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Expression of a multidrug-resistance gene in human tumors and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance in vivo cytostatic activity and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Clinical pharmacokinetics of cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Cyclosporine kinetics in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04770.X

10.1002/J.1552-4604.1997.TB04770.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference